Devon Dental Laboratories Limited 06405048 false 2023-02-01 2024-01-31 2024-01-31 The principal activity of the company is that of dental laboratory. Digita Accounts Production Advanced 6.30.9574.0 true true 06405048 2023-02-01 2024-01-31 06405048 2024-01-31 06405048 core:CurrentFinancialInstruments 2024-01-31 06405048 core:CurrentFinancialInstruments core:WithinOneYear 2024-01-31 06405048 core:Non-currentFinancialInstruments 2024-01-31 06405048 core:Non-currentFinancialInstruments core:AfterOneYear 2024-01-31 06405048 core:Goodwill 2024-01-31 06405048 core:FurnitureFittings 2024-01-31 06405048 core:LandBuildings core:LongLeaseholdAssets 2024-01-31 06405048 1 2024-01-31 06405048 bus:SmallEntities 2023-02-01 2024-01-31 06405048 bus:AuditExemptWithAccountantsReport 2023-02-01 2024-01-31 06405048 bus:FilletedAccounts 2023-02-01 2024-01-31 06405048 bus:SmallCompaniesRegimeForAccounts 2023-02-01 2024-01-31 06405048 bus:RegisteredOffice 2023-02-01 2024-01-31 06405048 bus:CompanySecretaryDirector1 2023-02-01 2024-01-31 06405048 bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 06405048 core:Goodwill 2023-02-01 2024-01-31 06405048 core:Buildings 2023-02-01 2024-01-31 06405048 core:FurnitureFittings 2023-02-01 2024-01-31 06405048 core:FurnitureFittingsToolsEquipment 2023-02-01 2024-01-31 06405048 core:LandBuildings core:LongLeaseholdAssets 2023-02-01 2024-01-31 06405048 countries:EnglandWales 2023-02-01 2024-01-31 06405048 1 2023-02-01 2024-01-31 06405048 2023-01-31 06405048 core:Goodwill 2023-01-31 06405048 core:FurnitureFittings 2023-01-31 06405048 core:LandBuildings core:LongLeaseholdAssets 2023-01-31 06405048 1 2023-01-31 06405048 2022-02-01 2023-01-31 06405048 2023-01-31 06405048 core:CurrentFinancialInstruments 2023-01-31 06405048 core:CurrentFinancialInstruments core:WithinOneYear 2023-01-31 06405048 core:Non-currentFinancialInstruments 2023-01-31 06405048 core:Non-currentFinancialInstruments core:AfterOneYear 2023-01-31 06405048 core:Goodwill 2023-01-31 06405048 core:FurnitureFittings 2023-01-31 06405048 core:LandBuildings core:LongLeaseholdAssets 2023-01-31 06405048 1 2023-01-31 06405048 1 2022-02-01 2023-01-31 06405048 1 2022-01-31 iso4217:GBP xbrli:pure

Registration number: 06405048

Devon Dental Laboratories Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 January 2024

 

Devon Dental Laboratories Limited

Contents

Statement of Financial Position

1 to 2

Notes to the Unaudited Financial Statements

3 to 9

 

Devon Dental Laboratories Limited

(Registration number: 06405048)
Statement of Financial Position as at 31 January 2024

Note

2024
£

2023
£

Fixed assets

 

Intangible assets

4

24,000

30,000

Tangible assets

5

65,286

69,890

 

89,286

99,890

Current assets

 

Stocks

6

2,795

2,795

Debtors

7

96,238

104,745

Cash at bank and in hand

 

688

516

 

99,721

108,056

Creditors: Amounts falling due within one year

8

(69,470)

(96,695)

Net current assets

 

30,251

11,361

Total assets less current liabilities

 

119,537

111,251

Creditors: Amounts falling due after more than one year

8

(22,667)

(39,667)

Provisions for liabilities

(3,186)

(3,027)

Net assets

 

93,684

68,557

Capital and reserves

 

Called up share capital

104

104

Profit and loss account

93,580

68,453

Shareholders' funds

 

93,684

68,557

For the financial year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

 

Devon Dental Laboratories Limited

(Registration number: 06405048)
Statement of Financial Position as at 31 January 2024 (continued)

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Statement of Comprehensive Income.

Approved and authorised by the director on 31 October 2024
 


Mrs J A Ward
Company secretary and director

 

Devon Dental Laboratories Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Petitor House
Nicholson Road
Torquay
Devon
TQ2 7TD

Principal activity

The principal activity of the company is that of dental laboratory.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are prepared in sterling which is the functional currency of the entity.

Going concern

The financial statements have been prepared on a going concern basis.

 

Devon Dental Laboratories Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2024 (continued)

2

Accounting policies (continued)

Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Accounting estimates and assumptions are made concerning the future and, by their nature, will rarely equal the related actual outcome.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Long leasehold property

2% straight line

Fixtures, fittings and equipment

20% reducing balance

 

Devon Dental Laboratories Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2024 (continued)

2

Accounting policies (continued)

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

5% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash at bank and in hand, demand deposits with banks, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value. In the statement of financial position, bank overdrafts are shown within borrowing or current liabilities

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Costs include all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition. .

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the statement of comprehensive income over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

 

Devon Dental Laboratories Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2024 (continued)

2

Accounting policies (continued)

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Financial instruments

Recognition and measurement
A financial asset or a financial liability is recognised only when the company becomes party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 9 (2023 - 9).

 

Devon Dental Laboratories Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2024 (continued)

4

Intangible assets

Goodwill
 £

Total
£

Cost or valuation

At 1 February 2023

120,000

120,000

At 31 January 2024

120,000

120,000

Amortisation

At 1 February 2023

90,000

90,000

Amortisation charge

6,000

6,000

At 31 January 2024

96,000

96,000

Carrying amount

At 31 January 2024

24,000

24,000

At 31 January 2023

30,000

30,000

5

Tangible assets

Long leasehold land and buildings
£

Fixtures and fittings
£

Total
£

Cost or valuation

At 1 February 2023

70,912

45,115

116,027

At 31 January 2024

70,912

45,115

116,027

Depreciation

At 1 February 2023

16,952

29,185

46,137

Charge for the year

1,418

3,186

4,604

At 31 January 2024

18,370

32,371

50,741

Carrying amount

At 31 January 2024

52,542

12,744

65,286

At 31 January 2023

53,960

15,930

69,890

Included within the net book value of land and buildings above is £52,543 (2023 - £53,960) in respect of long leasehold land and buildings.
 

 

Devon Dental Laboratories Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2024 (continued)

6

Stocks

2024
£

2023
£

Raw materials and consumables

2,795

2,795

7

Debtors

2024
£

2023
£

Trade debtors

41,964

52,365

Other debtors

51,396

49,272

Prepayments

2,878

3,108

96,238

104,745

8

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Loans and borrowings

10

18,544

37,908

Trade creditors

 

11,612

12,375

Taxation and social security

 

31,861

39,013

Accruals and deferred income

 

5,970

5,674

Other creditors

 

1,483

1,725

 

69,470

96,695

Creditors: amounts falling due after more than one year

Note

2024
£

2023
£

Due after one year

 

Loans and borrowings

10

22,667

39,667

9

Reserves

Profit and loss account:

This reserve records retained earnings and accumulated losses.

 

Devon Dental Laboratories Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2024 (continued)

10

Loans and borrowings

Non-current loans and borrowings

2024
£

2023
£

Bank borrowings

22,667

39,667

Current loans and borrowings

2024
£

2023
£

Bank borrowings

17,000

17,000

Bank overdrafts

1,544

20,908

18,544

37,908

11

Financial commitments, guarantees and contingencies

Amounts not provided for in the statement of financial position

The total amount of financial commitments not included in the statement of financial position is £6,667 (2023 - £6,667).

12

Related party transactions

Transactions with the director

2024

At 1 February 2023
£

Advances to director
£

Repayments by director
£

At 31 January 2024
£

Directors

49,272

55,771

(53,647)

51,396

         
       

 

2023

At 1 February 2022
£

Advances to director
£

Repayments by director
£

At 31 January 2023
£

Directors

58,153

55,679

(64,560)

49,272